- £155.12m
- £183.62m
- £208.44m
- 50
- 96
- 37
- 68
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 13 | 86.8 | 208 |
Cost of Revenue | |||||
Gross Profit | — | — | 0.062 | 21.7 | 78.7 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2.37 | 7.23 | -4.99 | 53.4 | 145 |
Operating Profit | -2.37 | -7.23 | 18 | 33.4 | 63.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.96 | -10.9 | 10.6 | 25.7 | 55.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.96 | -10.9 | 11.7 | 25.1 | 42 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.96 | -10.9 | 11.7 | 25.1 | 42 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.96 | -10.9 | 11.7 | 25.1 | 42 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.051 | -0.134 | -0.011 | 0.001 | 0.034 |
Dividends per Share | |||||
Special Dividends per Share |